Protective effects of antisense oligonucleotides (ASOs) targeting Snca mRNA (IMAGE)

Tokyo Medical and Dental University

Protective effects of antisense oligonucleotides (ASOs) targeting Snca mRNA

Caption

Researchers from Japan investigated how ASOs administered locally into the brains of mice models for Parkinson’s disease can help prevent the formation and spread of harmful aSyn aggregates through different regions. Their findings show ASOs could be a promoting therapeutic strategy to both prevent and control the progression of various neurodegenerative diseases.

Credit

Department of Neurology and Neurological Science, TMDU

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.